Invivyd

NEWS

Adagio Raises $336 Million to Support Development of COVID-19 Antibody Candidate

The new financing round was led by RA Capital Management, in tandem with new investors Redmile Group, Federated Hermes, Foresite Capital, ArrowMark Partners, PremjiInvest, and another unnamed investor from the health care space.

April 19, 2021

3 min read

Brandon May

JOBS

IN THE PRESS

Press Releases

Invivyd Announces Receipt of Twelve Months’ Advanced Notice of Emergency Use Authorization (EUA) Termination for PEMGARDA® and Provides an Update on Next Steps with the U.S. FDA

July 6, 2026

11 min read

Press Releases

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 2, 2026

July 2, 2026

1 min read

Press Releases

Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine

June 16, 2026

9 min read

Press Releases

Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safety and Immunology of Antibody and mRNA Vaccine Co-Administration

June 9, 2026

10 min read

Press Releases

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 3, 2026

June 3, 2026

1 min read

Press Releases

Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID

June 1, 2026

9 min read

Press Releases

Invivyd to Participate in Upcoming June 2026 Investor Events

May 27, 2026

1 min read

Press Releases

Invivyd Reports First Quarter 2026 Financial Results and Recent Business Highlights

May 14, 2026

25 min read

Press Releases

Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination

May 11, 2026

10 min read

Press Releases

Invivyd to Host First Quarter 2026 Financial Results and Corporate Update Call on May 14, 2026

May 7, 2026

1 min read